Government of Peru   Report issue

Government Phase 4

Organization Overview

First Clinical Trial
2014
NCT02084602
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

CONCYTEC | NAMRU 6

Active Ingredients

Drugs in Phase 4 Trials (2)

artesunate (1 trial)

mefloquine (lariam) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria, Falciparum (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2